L851-2311 Screening compound: 1-[3-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-1-methyl-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-5-yl]-3-methoxypropan-1-one

L851-2311 Screening compound: 1-[3-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-1-methyl-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-5-yl]-3-methoxypropan-1-one
L851-2311 Screening compound: 1-[3-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-1-methyl-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-5-yl]-3-methoxypropan-1-one alternative view

Chemical Structure Depiction of ChemDiv screening compound L851-2311
1-[3-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-1-methyl-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-5-yl]-3-methoxypropan-1-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L851-2311

Molecular Formula

C16H21N5O3 (C16 H21 N5 O3)

Compound Name

1-[3-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-1-methyl-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-5-yl]-3-methoxypropan-1-one

IUPAC name

1-[3-(3-cyclopropyl-124-oxadiazol-5-yl)-1-methyl-1H4H5H6H7H-pyrazolo[43-c]pyridin-5-yl]-3-methoxypropan-1-one

SMILES

Cn(c(CC1)c2CN1C(CCOC)=O)nc2-c1nc(C2CC2)no1

InChI

InChI=1S/C16H21N5O3/c1-20-12-5-7-21(13(22)6-8-23-2)9-11(12)14(18-20)16-17-15(19-24-16)10-3-4-10/h10H,3-9H2,1-2H3

InChI Key

WISVUWADQJDTRT-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD28120115

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

331.37

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

0.609

Distribution Coefficient, logD

0.609

Water Solubility, LogSw

-0.48

Polar Surface Area

71.582

Acid Dissociation Constant (pKa)

22.82

Base Dissociation Constant (pKb)

0.60

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

62.50

L851-2311 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

CNS MPO Library (28609 compounds)

Protein-Protein Interaction Library (218420 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Mechanism of action:
  • PPI modulators
  • Receptor's ligands
Targets:
  • GPCR
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with L851-2311 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L851-2311?
Check Price and Availability of L851-2311, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L851-2311 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L851-2311
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L851-2311
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L851-2311 available by request